COVID-19 and Diabetes, Post-COVID Diabetes
COVID-19 and diabetes are closely linked, as individuals with diabetes are at higher risk for severe illness, complications, and death from the virus. The pandemic has also highlighted how COVID-19 can disrupt glucose control, leading to hyperglycemia (high blood sugar) or diabetic ketoacidosis (DKA) in some people, particularly those with undiagnosed or poorly managed diabetes. Additionally, emerging evidence suggests that COVID-19 may trigger new-onset diabetes in some individuals, particularly in those with predispositions like obesity or genetic factors. Post-COVID diabetes refers to the onset of diabetes or worsening of pre-existing diabetes following a COVID-19 infection. This phenomenon is being actively studied, with theories suggesting that the virus may impact insulin sensitivity or pancreatic function. Proper management of blood glucose and monitoring is essential for individuals recovering from COVID-19, particularly for those experiencing changes in their metabolic health.
